The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials

The devastating Ebola virus (EBOV) epidemic in West Africa in 2013–2016 accelerated the progress of several vaccines and antivirals through clinical trials, including the replication-competent vesicular stomatitis virus-based vaccine expressing the EBOV glycoprotein (VSV-EBOV). Extensive preclinical...

Full description

Bibliographic Details
Main Authors:	Ellen Suder, Wakako Furuyama, Heinz Feldmann, Andrea Marzi, Emmie de Wit
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-09-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	vsv-ebov animal models clinical trials filovirus preclinical testing phase 1 phase 2 phase 3
Online Access:	http://dx.doi.org/10.1080/21645515.2018.1473698

Similar Items

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
by: Bharti Bhatia, et al.
Published: (2021-06-01)

Closer than ever to an Ebola virus vaccine
by: Logan Banadyga, et al.
Published: (2017-05-01)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
by: Andrea R. Menicucci, et al.
Published: (2019-06-01)

Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection
by: Wakako Furuyama, et al.
Published: (2020-10-01)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Andrea Marzi, et al.
Published: (2015-02-01)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
by: Emmie de Wit, et al.
Published: (2015-04-01)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
by: Anahita Fathi, et al.
Published: (2019-10-01)

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
by: Andrea Marzi, et al.
Published: (2019-01-01)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
by: Igor Morozov, et al.
Published: (2021-01-01)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
by: Amanda N. Pinski, et al.
Published: (2020-09-01)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
by: Takeshi Saito, et al.
Published: (2020-08-01)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
by: Katherine E. Havranek, et al.
Published: (2021-12-01)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
by: Neil Rupani, et al.
Published: (2022-06-01)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
by: Lamin B. Cham, et al.
Published: (2019-09-01)

Differences in Tissue and Species Tropism of Reptarenavirus Species Studied by Vesicular Stomatitis Virus Pseudotypes
by: Yegor Korzyukov, et al.
Published: (2020-04-01)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
by: Suman Bishnoi, et al.
Published: (2018-02-01)

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
by: Mai Izumida, et al.
Published: (2020-04-01)

The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion
by: Emmanuel Heilmann, et al.
Published: (2019-10-01)

Lessons from Pasteur may help prevent the deadly relapse of Ebola in patients: Using contingency vaccination to avoid Ebola relapse in immune-privileged organs
by: Wei Ye, et al.
Published: (2023-03-01)

Dendritic Cells Generated From Mops condylurus, a Likely Filovirus Reservoir Host, Are Susceptible to and Activated by Zaire Ebolavirus Infection
by: Kathryn M. Edenborough, et al.
Published: (2019-10-01)

Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses
by: Amanda N. Pinski, et al.
Published: (2021-01-01)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
by: Thomas P. Monath, et al.
Published: (2023-09-01)

Detection of buffaloes (Bubalus bubalis) seroreactive for vesicular stomatitis virus in the state of Paraíba, Northeastern Brazil
by: Camila de Sousa Bezerra, et al.
Published: (2019-10-01)

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
by: Almohanad A. Alkayyal, et al.
Published: (2023-01-01)

<i>Bacillus paranthracis</i> Isolate from Blood of Fatal Ebola Virus Disease Case
by: M. Jeremiah Matson, et al.
Published: (2020-06-01)

Respuesta inmune humoral de una vacuna comercial contra la estomatitis vesicular en cerdos Humoral immune response induced by a commercial vaccine against vesicular stomatitis virus (VSV) in pigs
by: John J Arboleda, et al.
Published: (2005-08-01)

Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
by: O'Donnell KL, et al.
Published: (2021-03-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays
by: Hongyue Li, et al.
Published: (2020-01-01)

Establishment of Replication Deficient Vesicular Stomatitis Virus for Studies of PEDV Spike-Mediated Cell Entry and Its Inhibition
by: Huaye Luo, et al.
Published: (2023-08-01)

IFN-I Independent Antiviral Immune Response to Vesicular Stomatitis Virus Challenge in Mouse Brain
by: Anurag R. Mishra, et al.
Published: (2020-06-01)

Vesicular Stomatitis Virus Elicits Early Transcriptome Response in <i>Culicoides sonorensis</i> Cells
by: Stacey L. P. Scroggs, et al.
Published: (2023-10-01)

Detection of Vesicular Stomatitis Virus Indiana from Insects Collected during the 2020 Outbreak in Kansas, USA
by: Bethany L. McGregor, et al.
Published: (2021-09-01)

On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization
by: Brett F. Beitzel, et al.
Published: (2021-10-01)

<i>Culicoides</i>-Specific Fitness Increase of Vesicular Stomatitis Virus in Insect-to-Insect Infections
by: Paula Rozo-Lopez, et al.
Published: (2024-01-01)

Vesicular stomatitis Indiana virus near-full-length genome sequences reveal low genetic diversity during the 2019 outbreak in Colorado, USA
by: Miranda R. Bertram, et al.
Published: (2023-02-01)

NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein
by: Zoleikha Mamizadeh, et al.
Published: (2021-12-01)

Cytopathogenesis of Vesicular Stomatitis Virus Is Regulated by the PSAP Motif of M Protein in a Species-Dependent Manner
by: Ronald N. Harty, et al.
Published: (2012-09-01)